Ligand Pharmaceuticals, Inc. (LGND)
204.87
+4.80
(+2.40%)
USD |
NASDAQ |
Jan 09, 13:11
Ligand Pharmaceuticals Research and Development Expense (Annual): 21.42M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Merck & Co., Inc. | 15.79B |
| Johnson & Johnson | 17.26B |
| Inspire Medical Systems, Inc. | 114.13M |
| Elanco Animal Health, Inc. | 344.00M |
| Alnylam Pharmaceuticals, Inc. | 1.126B |